FDA Adverse Event Injury Summary report: N

NI

MDR report key: 22668279 · Received July 30, 2025

Report

Report Number
3030306055-2025-00144
Event Type
Injury
Date Received
July 30, 2025
Date of Event
July 8, 2025
Report Date
July 30, 2025
Manufacturer
VANTIVE US HEALTHCARE LLC
Product Code
KDJ
PMA / PMN Number
NI
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
IN
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL
Health Professional
Yes

Narratives

Additional Manufacturer Narrative · 0

THIS REPORT IS FOR A BREACH IN ASEPTIC TECHNIQUE WHICH RESULTED IN PERITONITIS. PER VANTIVE LABELING, USERS ARE INSTRUCTED TO USE ASEPTIC TECHNIQUE WHEN PERFORMING PERITONEAL DIALYSIS THERAPY. SHOULD ADDITIONAL RELEVANT INFORMATION BECOME AVAILABLE, A SUPPLEMENTAL REPORT WILL BE SUBMITTED.

Description of Event or Problem · 0

IT WAS REPORTED THAT A PATIENT EXPERIENCED A BREACH IN ASEPTIC TECHNIQUE WHICH RESULTED IN PERITONITIS. THE BREACH IN ASEPTIC TECHNIQUE WAS NOT FURTHER DESCRIBED. THE PERITONITIS WAS MANIFESTED BY CLOUDY PD EFFLUENT AND ABDOMINAL PAIN. THE SAME DAY AS EVENT ONSET, THE PATIENT WAS HOSPITALIZED AND TREATED WITH INJECTION CEFTAZIDIME (1GM, ONCE DAILY, INTRAPERITONEAL, DISCONTINUED AFTER 14DAYS) AND INJECTION CEFAZOLIN (1GM, ONCE DAILY, INTRAPERITONEAL, DISCONTINUED AFTER 14DAYS) FOR PERITONITIS. THE PATIENT WAS DISCHARGED THREE DAYS AFTER HOSPITAL ADMISSION. ON AN UNKNOWN DATE, THE PATIENT RECOVERED FROM THE PERITONITIS EVENT. PD THERAPY WAS ONGOING. IT WAS REPORTED THE PATIENT WAS RETRAINED ON THE PROPER ASEPTIC TECHNIQUE. NO ADDITIONAL INFORMATION IS AVAILABLE.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
445750 NI SET, ADMINISTRATION, FOR PERITONEAL DIALYSIS, DISPOSABLE KDJ VANTIVE US HEALTHCARE LLC NA NI

Patients

Seq Age Sex Outcome Treatment
1 63 YR Female Required Intervention| H DIANEAL 2.5% PD2| NON-VANTIVE CATHETER